Digna de Bruin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Digna de Bruin has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Barbara Horváth
Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
1 shared publication C.J.G. Sanders
Department of Dermatology University Medical Center Utrecht the Netherlands
1 shared publicationE.R.M. de Haas
Department of Dermatology Erasmus Medical Center Rotterdam The Netherlands
1 shared publicationJ.C.J.M. Veraart
Department of Dermatology Maastricht University Medical Center Maastricht The Netherlands
1 shared publication- Koen D. Quint
Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands
1 shared publication M.M. van Rossum
Department of Dermatology Radboud University Medical Center Nijmegen the Netherlands
1 shared publication
Latest Publications
- Open Access
- 10 March 2021
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 185 (2) , 434-435
Incidence of mycosis fungoides and Sézary syndrome in the Netherlands between 2000 and 2020
Cutaneous T‐cell lymphomas (CTCL) are a heterogeneous group of non‐Hodgkin lymphomas that differ greatly in clinical presentation and prognosis. Mycosis fungoides (MF) is the most frequent subtype of cutaneous lymphomas. Sezary syndrome (SS), characterized by the triad of erythroderma, lymphadenopathy and blood involvement, is less prevalent, and has a much more unfavorable prognosis.
- 10 March 2021
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 185 (2) , 434-435
Open AccessIncidence of mycosis fungoides and Sézary syndrome in the Netherlands between 2000 and 2020
Cutaneous T‐cell lymphomas (CTCL) are a heterogeneous group of non‐Hodgkin lymphomas that differ greatly in clinical presentation and prognosis. Mycosis fungoides (MF) is the most frequent subtype of cutaneous lymphomas. Sezary syndrome (SS), characterized by the triad of erythroderma, lymphadenopathy and blood involvement, is less prevalent, and has a much more unfavorable prognosis.